Pascal Neuville

Pascal Neuville is an experienced executive with a strong background in leadership and strategic roles in various companies within the biotechnology and pharmaceutical sectors. Currently serving as the Chairman of the Board of Directors for Quest for Change and Axilum Robotics, Pascal Neuville has also held significant positions such as Chief Executive Officer at Domain Therapeutics and member of the Investment Committee at SATT Conectus Alsace. Previous roles include Chief Scientific Officer at Faust Pharmaceuticals and Project Leader at Transgene. Pascal Neuville’s academic credentials include a PhD in Molecular and Cell Biology from the University of Geneva and a degree from the University of Strasbourg.